Sun Pharma Advanced Research Company Ltd reported weak set of numbers for quarter Q4FY21 By Mr. Yash Gupta, Angel Broking Ltd
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Below are Quote on SPARC limited reported weak set of numbers for quarter Q4FY21. by Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd
Sun Pharma Advanced Research Company Limited reported total revenue from operations at ₹28.06 crores up by 23% YoY from ₹ 22.7 crores in Q4FY20. Loss before tax at 56.72 crores in Q4FY21 as compared to loss before tax of 99.5 crores in Q4FY20, company able to save its cost on clinical trials expenses in this quarter. Company has reported a negative EPS of 2.16 for the quarter Q4FY21 and negative EPS of 5.77 for the year ended 2021.
Sun Pharma Advanced Research Company Limited reported another weak set of numbers, this year losses for the year have come down but still no sign of turnaround as of now. We suggest retail investors to be cautious on the stock.
Above views are of the author and not of the website kindly read disclaimer
.jpg)
Tag News
On the higher side, immediate resistance is seen around 36000 - 36200 levels - Angel One
